Cheng Andrew — SEC Form 4 filings
SEC reporting owner CIK 1778307. 33 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2024-03-06 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 45 legs across 20 filings — 637,447 shares, $25,361,284 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
- Largest priced transaction: sale of 81,280 shares @ $31.47 ($2,558,044) in Akero Therapeutics, Inc., filed 2024-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) | President and CEO, Director | 29 | — | 45 legs · 637,447 sh · $25,361,284 | 50 |
| Vera Therapeutics, Inc. (VERA) | Director | 3 | — | — | 3 |
| Damora Therapeutics, Inc. (DMRA) | Director | 1 | — | — | 1 |
Form 4 filings — Cheng Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Damora Therapeutics, Inc. (DMRA) | Grant/award (A): 30,350 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 17,084 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 277,075 · Disposition to issuer (D): 159,762 · Disposition to issuer (D): 3,421 (derivative) · Disposition to issuer (D): 5,032 (derivative) · Disposition to issuer (D): 2,328 (derivative) · Disposition to issuer (D): 4,739 (derivative) · +10 more | EDGAR |
| 2025-11-21 | 4 | Akero Therapeutics, Inc. (AKRO) | Gift (G): 74,538 @ $0 | EDGAR |
| 2025-11-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Gift (G): 14,739 @ $0 | EDGAR |
| 2025-10-14 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 30,000 @ $19.87 · Sale (S): 30,000 @ $53.98 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-10-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 52,212 @ $0.61 · Option exercise (M): 52,212 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 13,022 @ $6.36 · Option exercise (M): 1,919 @ $19.87 · Sale (S): 22,525 @ $42.99 · Sale (S): 7,317 @ $43.99 · Sale (S): 158 @ $44.62 · Sale (S): 1,796 @ $43.02 · +2 more | EDGAR |
| 2025-08-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 10,795 @ $48.07 · Sale (S): 18,805 @ $48.87 · Sale (S): 400 @ $49.44 | EDGAR |
| 2025-07-11 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 14,686 @ $50.57 · Sale (S): 15,314 @ $51.73 | EDGAR |
| 2025-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 890 @ $23.87 | EDGAR |
| 2025-06-20 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 6,620 @ $54.84 | EDGAR |
| 2025-06-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 14,842 @ $53.76 · Sale (S): 15,158 @ $54.35 · Sale (S): 7,837 @ $53.99 | EDGAR |
| 2025-05-16 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 7,200 @ $41 · Sale (S): 22,800 @ $41.63 | EDGAR |
| 2025-04-11 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 30,000 @ $35.23 | EDGAR |
| 2025-03-14 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 1,738 @ $44.88 | EDGAR |
| 2025-03-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 28,784 @ $41.75 · Sale (S): 1,216 @ $42.31 | EDGAR |
| 2025-02-11 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 12,640 @ $51.75 · Sale (S): 6,439 @ $52.91 · Sale (S): 9,972 @ $53.67 · Sale (S): 749 @ $54.55 · Sale (S): 200 @ $55.81 | EDGAR |
| 2025-01-29 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 24,242 @ $54.56 · Sale (S): 2,381 @ $55.53 · Sale (S): 3,377 @ $56.89 | EDGAR |
| 2025-01-27 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 50,000 @ $0.61 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 98,500 @ $0 · Grant/award (A): 295,600 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 7,855 @ $30.79 | EDGAR |
| 2024-12-04 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 25,000 @ $21.10 · Sale (S): 25,000 @ $32.09 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 81,280 @ $21.10 · Sale (S): 81,280 @ $31.47 · Option exercise (M): 27,086 @ $21.10 · Sale (S): 27,086 @ $32.50 · Option exercise (M): 81,280 (derivative) @ $0 · Option exercise (M): 27,086 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 24,992 @ $21.10 · Sale (S): 24,992 @ $31.14 · Option exercise (M): 3,103 @ $21.10 · Sale (S): 3,103 @ $31.12 · Option exercise (M): 63,539 @ $21.10 · Sale (S): 63,313 @ $31.53 · +4 more | EDGAR |
| 2024-09-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 1,738 @ $26.18 | EDGAR |
| 2024-08-20 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 24,538 @ $0.61 · Option exercise (M): 24,538 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 1,064 @ $19.94 | EDGAR |
| 2024-06-13 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 7,894 @ $22.64 | EDGAR |
| 2024-05-17 | 4 | Vera Therapeutics, Inc. (VERA) | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | Akero Therapeutics, Inc. (AKRO) | Sale (S): 1,969 @ $28.33 | EDGAR |
| 2024-03-06 | 4 | Akero Therapeutics, Inc. (AKRO) | Option exercise (M): 57,733 @ $16 · Option exercise (M): 17,267 @ $21.10 · Sale (S): 35,827 @ $31.40 · Sale (S): 6,770 @ $32.28 · Sale (S): 9,614 @ $33.83 · Sale (S): 14,680 @ $34.63 · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1778307 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →